NCT04746105View on ClinicalTrials.gov

A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Patients with Mild Obstructive Sleep Apnea Hypopnea
Interventions
DRUG

TS-142

Subjects received single-dose of 10 mg of TS-142 (oral tablet)

DRUG

Dose-matched Placebo to TS-142

Subjects received single-dose matched placebo to TS-142 (oral tablet)

Trial Locations (1)

Unknown

Taisho Pharmaceutical Co., Ltd selected site, Tokyo

All Listed Sponsors
lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT04746105 - A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea. | Biotech Hunter | Biotech Hunter